Table 2. First-Line Chemotherapy Regimens.
ABVD: Adriamycin (doxorubicin), bleomycin, vinblastine, dacarbazine; CHOEP: cyclophosphamide, doxorubicin, etoposide, vincristine, prednisone; CODOX: cyclophosphamide, vincristine, doxorubicin; R-CHOP: rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone; R-EPOCH: rituximab, etoposide phosphate, prednisone, vincristine sulfate (Oncovin), cyclophosphamide, and doxorubicin hydrochloride (hydroxydaunorubicin)
| Chemotherapy regimens | All Patients n (%) | Indolent n (%) | Aggressive n (%) | P-value |
| R-CHOP | 8 (40) | 4 (40) | 4 (40) | 1 |
| Rituximab | 4 (20) | 3 (30) | 1 (10) | 0.58 |
| R-EPOCH | 3 (15) | 0 (0) | 3 (30) | 0.21 |
| Rituximab/bendamustine | 2 (10) | 2 (20) | 0 (0) | 0.47 |
| ABVD | 1 (5) | 1 (10) | 0 (0) | 1 |
| CHOEP | 1 (5) | 0 (0) | 1 (10) | 1 |
| CODOX | 1 (5) | 0 (0) | 1 (10) | 1 |